-
Mashup Score: 0Functional Recovery after Partial Nephrectomy in a Solitary Kidney - Beyond the Abstract - 1 hour(s) ago
renal mass, renal cell carcinoma (RCC), kidney cancer, Partial Nephrectomy (PN), Radical Nephrectomy (RN), renal mass in a solitary kidney (RMSK), chronic kidney disease (CKD), parenchymal volume loss, Acute kidney injury (AKI).
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
AUA 2024 results of a phase 1 dose-escalation trial of multiple and fractionated-dose PSMA-targeted alpha radionuclide 225Ac-J591, metastatic castration-resistant prostate cancer (mCRPC), advanced prostate cancer.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6AUA 2024: Smoking Status is Associated with Poor Mental Health in Bladder Cancer Patients and Survivors - 2 hour(s) ago
AUA 2024, bladder cancer, smoking effects on bladder cancer, adverse cancer effects from smoking, smoking effects on mental health.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
AUA 2024, Quality of Treatment with Targeted Therapies for Advanced Prostate Cancer, Targeted Therapies by Specialist, Targeted Therapies for prostate cancer, abiraterone, androgen receptor inhibitor (ARI), abiraterone versus other androgen receptor inhibitor, prostate cancer treatment adherence.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Quality of treatment with targeted therapies for advanced #ProstateCancer by a specialist: do patients who are managed by #Urologists fare differently? Presented by @KassemFarajMD @UMichUrology. #AUA24 written coverage by @RKSayyid @UofT > https://t.co/p4zbkYzPPi @AmerUrological https://t.co/fkT0Yd2xW2
-
-
Mashup Score: 1Collaborating on Triplet Therapy for Metastatic Hormone-Sensitive Prostate Cancer - Daniel Saltzstein - 2 hour(s) ago
Zach Klaassen converses with Daniel Saltzstein about the collaborative approach in treating metastatic hormone-sensitive prostate cancer with triplet therapy. Dr. Saltzstein describes their unique setup in San Antonio, where a medical oncologist is part of their urology team, facilitating seamless collaboration and treatment intensification. They focus on identifying high-volume, high-risk…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4AUA 2024: Prostate-Specific Antigen Dynamics from the Phase 3 EMBARK Trial: A Post Hoc Analysis - 3 hour(s) ago
AUA 2024: Prostate-Specific Antigen Dynamics, EMBARK Trial, enzalutamide, leuprolide, enzalutamide plus leuprolide combination therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
AUA 2024, metastatic castration-sensitive prostate cancer (mCSPC), IMPLEMENT study, IMPLEMENT study barriers, IMPLEMENT study facilitators, IMPLEMENT study barrier to facilitator, androgen-deprivation therapy (ADT).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Differences in barriers and facilitators to first-line treatment intensification in #mCSPC between #Urologists and #Oncologists: a sub-analysis of the #IMPLEMENT study. Presentation by @LoebStacy @nyulangone. #AUA24 written coverage by @RKSayyid @UofT > https://t.co/a4q7VVNlMh https://t.co/JyLs3Khkbd
-
-
Mashup Score: 4
AUA 2024 BOND-003, intravesical cretostimogene grenadenorepvec for the treatment of high risk BCG-unresponsive non-muscle invasive bladder cancer, Coxsackie Adenovirus Receptor (CAR).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Pivotal results from #BOND-003: a phase 3, single-arm Study of Intravesical cretostimogene grenadenorepvec for the treatment of high risk, BCG-unresponsive #NMIBC. Presentation by @MarkTysonMD @MayoClinic. #AUA24 coverage by @zklaassen_md > https://t.co/JI6cGxLFSU @AmerUrological https://t.co/3c1nf02gd6
-
-
Mashup Score: 6AUA 2024: Analyzing the Percentage of Positive 68Ga-PSMA-PET/CT Scans Based on PSA Ranges Across Distinct Indications for the Scan - 4 hour(s) ago
AUA 2024, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), 68Ga-PSMA-PET/CT, Positive 68Ga-PSMA-PET/CT Scans Based on PSA Ranges.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 9Breaking Paradigms: BOND-003's Cretostimogene Monotherapy for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mark Tyson - 4 hour(s) ago
Mark Tyson presents results from the BOND-003 study, evaluating the efficacy of cretostimogene grenadenorepvec monotherapy in treating BCG-unresponsive non-muscle-invasive bladder cancer. Cretostimogene, an oncolytic adenovirus, selectively targets and destroys cancer cells while sparing normal tissue and boosting antitumor immunity. The phase III study reported a 75.2% complete response rate,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Functional recovery after partial nephrectomy in a solitary kidney. #BeyondTheAbstract with Carlos Munoz-Lopez, @KieranLew1, and Steven Campbell, MD, PhD @CleClinicUro. #ReadNow on UroToday > https://t.co/8c5dgdJy0g https://t.co/HGq9u9x2yo